Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Am J Transplant ; 15(11): 2814-24, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26147452

ABSTRACT

Epstein-Barr virus (EBV) is a γ-herpesvirus that is linked to the development of posttransplant lymphoproliferative disorder (PTLD) in solid organ recipients. We previously demonstrated that EBV(+) B cell lymphoma cell lines isolated from patients with PTLD produce human IL-10 as an autocrine growth factor. However, little is known regarding IL-10 regulation in B cells. Here we show that EBV infection markedly alters the expression of host B cell microRNA, a class of small noncoding RNA that is an important regulator of transcriptional and posttranscriptional gene expression. Gene arrays reveal unique microRNA profiles in EBV(+) B cell lymphoma lines from patients with PTLD, compared to normal B cells or in vitro generated EBV(+) lymphoblastoid cell lines. We show that microRNA-194 expression is uniquely suppressed in EBV(+) B cell lines from PTLD patients and that the 3'untranslated region of IL-10 is targeted by microRNA-194. Overexpression of microRNA-194 attenuates IL-10 production and increases apoptosis of EBV(+) B cell lymphoma lines. Together, these data indicate that EBV co-opts the host B cell microRNA network and specifically suppresses microRNA-194 to override control of IL-10 expression. Thus, modulation of microRNA-194 may constitute a novel approach to inhibiting proliferation of EBV(+) B cell lymphomas in PTLD.


Subject(s)
Epstein-Barr Virus Infections/virology , Herpesvirus 4, Human/genetics , Interleukin-10/metabolism , Lymphoma, B-Cell/pathology , Lymphoproliferative Disorders/virology , B-Lymphocytes/pathology , Cell Survival , Epstein-Barr Virus Infections/pathology , Gene Expression Regulation, Neoplastic , Humans , Lymphoma, B-Cell/genetics , Lymphoproliferative Disorders/pathology , MicroRNAs/metabolism , Organ Transplantation/adverse effects , Real-Time Polymerase Chain Reaction/methods , Reference Values , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL